Table 1.
Authors, Country (Year) | Study period | Study type | Participant | No. of cycles and oocytes/embryos thawed | Outcomes | Funding | Overall quality assessment | |
---|---|---|---|---|---|---|---|---|
Study (Closed) | Control (Open) | |||||||
Kuwayama et al. (2005), Japan | NM | Prospective | Embryo | 88 embryos | 227 embryos | CsR; CPR; LBR | None declared | Moderate risk |
Chen et al. (2013), China | 2010.04–2012.05 | Retrospective | Embryo | 226 cycles; 308 embryos | 106 cycles; 150 embryos | CsR; IR; CaR; CPR; OPR; MR; LBR; BB; MR | Yes | Low risk |
Panagiotidis et al. (2013), Greece | 2009.06–2011.09 | Prospective | Embryo | 224 cycles; 513 embryos | 208 cycles; 492 embryos | CsR; PβR; IR; CaR; CPR; OPR; MR; LBR; BB; MR | None declared | Low risk |
Desai et al. (2013), America | 2011.01–2012.08 | Retrospective | Embryo | 95 cycles; 184 embryos | 161 cycles; 302 embryos | CsR; IR; CaR; CPR; OPR; MR; LBR; BB; MR | None declared | Low risk |
Hashimoto et al. (2013), Japan | 2011.07–2012.09 | Prospective | Embryo | 100 embryos | 163 embryos | CsR; IR; OPR | Yes | Moderate risk |
Roy et al., Australia (2014) | NM | Prospective | Embryo | 23 embryos | 13 embryos | CsR; OPR | Yes | Serious risk |
Iwahata et al. (2015), Japan | 2011.11–2013.12 | Retrospective | Embryo | 302 cycles; 313 embryos | 539 cycles; 561 embryos | CsR; IR; CPR; MR; LBR; MR | None declared | Low risk |
Paffoni et al. (2011), Italy | 2007.06–2009.04 | Retrospective | Oocyte/embryo | 51 cycles; 261 MII oocytes/87 embryos | 53 cycles; 268 MII oocytes/116 embryos | CsR; IR; FR; ClR; GQER; CPR; LBR | None declared | Low risk |
Papatheodorou et al. (2013), Greece | 2007.02–2010.12 | Prospective | Oocyte | 598 MII oocytes | 608 MII oocytes | CsR; FR; ClR; GQER; PβR; IR; CPR; MR; OPR; LBR | None declared | Low risk |
De Munck et al. (2016), Belgium | 2014.01–2015.07 | Prospective | Oocyte/embryo | 253 MII oocytes | 257 MII oocytes | CsR; FR; GQER; PβR; MR; OPR | No funding | Low risk |
Gook et al. (2016), Australia | 2012.06–2015.06 | Prospective | Oocyte | 39 MII oocytes | 79 MII oocytes | CsR | None declared | Serious risk |
Sarandi et al. (2016), France | 2014.11–2015.05 | Prospective | Oocyte | 96 GV/MI oocytes | 118 GV/MI oocytes | CsR | None declared | Serious risk |
Notes: The ROBINS-I tool was used for quality assessment of observational studies. BB babies born per transferred blastocysts, CaR cancellation rate, CBS Cryo Bio System, ClR cleavage rate, CPR clinical pregnancy rate, CsR cryosurvival rate, FR fertilization rate, GQER good quality embryo rate, HSV high security straws, IR implantation rate, LBR: live birth rate, MBR multiple birth rate, MR miscarriage rate, NM not mentioned, OPR ongoing pregnancy rate, PβR positive βHCG rate